Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Prakash Ambady

Showing results (21-30 of 35) with videos related to

Pageof 4
Sort By:
Neuro-Oncology Practice|May 23, 2022
[<sup>18</sup>F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumabRamon F Barajas, Prakash Ambady, Jeanne Link, et al.
Neurosurgery|February 6, 2021
Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case StudiesKutluay Uluc, Dominic A Siler, Ricardo Lopez, et al.
CNS Oncology|December 16, 2020
The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case seriesStephen G Bowden, Daniel N Munger, Jaclyn Thiessen, et al.
Neuro-Oncology Advances|December 11, 2023
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypesJared Stoller, Cymon N Kersch, Leslie L Muldoon, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
The Neuroradiology Journal|March 28, 2024
Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRIDoonyaporn Wongsawaeng, Daniel Schwartz, Xin Li, et al.
Magnetic Resonance in Medicine|December 6, 2017
Quantitative comparison of delayed ferumoxytol T<sub>1</sub> enhancement with immediate gadoteridol enhancement in high grade gliomasAndrea Horváth, Csanad G Varallyay, Daniel Schwartz, et al.
Neuro-Oncology Advances|September 9, 2020
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survivalCymon N Kersch, Cheryl J Claunch, Prakash Ambady, et al.
Neuro-Oncology Advances|July 27, 2022
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumorsKutluay Uluc, Prakash Ambady, Matthew K McIntyre, et al.
The Oncologist|March 31, 2025
A pilot survey into the landscape of neuro-oncology care in the communityChristine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha, et al.
Pageof 4

Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
Neuro-Oncology Practice|May 23, 2022
[<sup>18</sup>F]-fluoromisonidazole (FMISO) PET/MRI hypoxic fraction distinguishes neuroinflammatory pseudoprogression from recurrent glioblastoma in patients treated with pembrolizumabRamon F Barajas, Prakash Ambady, Jeanne Link, et al.
Neurosurgery|February 6, 2021
Long-Term Outcomes of Intra-Arterial Chemotherapy for Progressive or Unresectable Pilocytic Astrocytomas: Case StudiesKutluay Uluc, Dominic A Siler, Ricardo Lopez, et al.
CNS Oncology|December 16, 2020
The clinical heterogeneity of entirely nonenhancing CNS lymphoma: a case seriesStephen G Bowden, Daniel N Munger, Jaclyn Thiessen, et al.
Neuro-Oncology Advances|December 11, 2023
Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypesJared Stoller, Cymon N Kersch, Leslie L Muldoon, et al.
Journal of Neuro-Oncology|June 14, 2015
Pre-radiation lymphocyte harvesting and post-radiation reinfusion in patients with newly diagnosed high grade gliomasJian L Campian, Xiaobu Ye, Douglas E Gladstone, et al.
The Neuroradiology Journal|March 28, 2024
Comparison of dynamic susceptibility contrast (DSC) using gadolinium and iron-based contrast agents in high-grade glioma at high-field MRIDoonyaporn Wongsawaeng, Daniel Schwartz, Xin Li, et al.
Magnetic Resonance in Medicine|December 6, 2017
Quantitative comparison of delayed ferumoxytol T<sub>1</sub> enhancement with immediate gadoteridol enhancement in high grade gliomasAndrea Horváth, Csanad G Varallyay, Daniel Schwartz, et al.
Neuro-Oncology Advances|September 9, 2020
Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survivalCymon N Kersch, Cheryl J Claunch, Prakash Ambady, et al.
Neuro-Oncology Advances|July 27, 2022
Safety of intra-arterial chemotherapy with or without osmotic blood-brain barrier disruption for the treatment of patients with brain tumorsKutluay Uluc, Prakash Ambady, Matthew K McIntyre, et al.
The Oncologist|March 31, 2025
A pilot survey into the landscape of neuro-oncology care in the communityChristine Lu-Emerson, Sajeel Chowdhary, Rupesh Kotecha, et al.
Pageof 4